Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

sector : Health care and social assistance    crawled time : 14:20    save search

Viridian Therapeutics to Participate in 32nd Annual Oppenheimer Healthcare Conference on March 15
Published: 2022-03-14 (Crawled : 14:20) - globenewswire.com
VRDN | $15.29 0.86% 470K twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: 0.25% H: 1.7% C: -1.68%

conference therapeutics
Viridian Therapeutics Doses First Subject in First-in-Human Clinical Trial Evaluating VRDN-002, a Next Generation IGF-1R Antibody for the Treatment of Thyroid Eye Disease
Published: 2022-03-21 (Crawled : 14:20) - globenewswire.com
VRDN | $15.29 0.86% 470K twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: 0.75% H: 6.59% C: 1.34%

vrdn-002 disease antibody treatment thyroid eye trial therapeutics
Viridian Therapeutics Secures Flexible Credit Facility for Up to $75 Million From Hercules Capital
Published: 2022-04-04 (Crawled : 14:20) - globenewswire.com
VRDN | $15.29 0.86% 470K twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: -0.79% H: 7.54% C: 0.75%
HTGC F | $18.4 0.82% 150K twitter stocktwits trandingview |
Finance
| | O: -0.16% H: 1.29% C: 0.71%

therapeutics
Biora Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
Published: 2023-03-23 (Crawled : 14:20) - biospace.com/
BIOR | $0.609 1.59% 12K twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: 0.36% H: 8.7% C: 4.35%

report year update therapeutics financial results
BioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
BICX | $1.47 200 twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: 3.25% H: 0.0% C: 0.0%

bicx104 treatment opioid trial study
Clubhouse Media Group, Inc. Closes Another Brand Deal With Sommer Ray, Social Media Star
Published: 2022-12-28 (Crawled : 14:20) - prnewswire.com
CMGR | $0.0003 14M twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: -33.33% H: 50.0% C: 50.0%

media deal star
Gainers vs Losers
79% 21%

Top 10 Gainers
AGBA | News | $1.22 205.0% 86M twitter stocktwits trandingview |
Finance

EGOX | $0.0606 68.33% 250M twitter stocktwits trandingview |

NVFY | $3.45 63.51% 20M twitter stocktwits trandingview |
Consumer Durables

CHRO | $1.66 35.51% 70K twitter stocktwits trandingview |
n/a

INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals

ZCMD | $1.86 28.28% 29M twitter stocktwits trandingview |
Commercial Services

PAPL | $2.07 26.22% 550K twitter stocktwits trandingview |

RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a

AULT | $0.3022 24.82% 51M twitter stocktwits trandingview |
Manufacturing

HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals


Your saved searches
Save your searches and get alerts when important news are released.